NCT05462574View on ClinicalTrials.gov

Right Ventricle Lipid in Pulmonary Arterial Hypertension (PAH)

RecruitingOBSERVATIONAL
Enrollment

75

Participants

Timeline

Start Date

January 17, 2023

Primary Completion Date

September 30, 2027

Study Completion Date

September 30, 2027

Conditions
Idiopathic Pulmonary Arterial HypertensionHeritable Pulmonary Arterial HypertensionPulmonary Arterial Hypertension Associated With Connective Tissue Disease
Interventions
OTHER

No Intervention

No Intervention

Trial Locations (1)

37232

RECRUITING

Vanderbilt University Medical Center, Nashville

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Vanderbilt University Medical Center

OTHER